Abstract
Background In patients with myocardial infarction with nonobstructive coronary arteries (MINOCA), cardiovascular magnetic resonance imaging (CMR) can often establish a causal diagnosis. It is unknown if CMR is warranted in patients with normal echocardiographic findings, or if measurement of high-sensitive troponin T (hs-TnT) and NT-pro-BNP can be of value in selecting patients for further imaging.
Objectives To assess the diagnostic accuracy of echocardiography and hs-TnT and NT-pro-BNP for identifying patients receiving any diagnosis using CMR.
Methods We included patients (n=123) from the SMINC2 study who underwent same day CMR and echocardiography, at a median of 3 days after hospital admission for MINOCA. Normal echocardiography was defined as left ventricular ejection fraction ≥55%, absolute global longitudinal strain ≥17%, E/e′≤14, and no regional wall motion abnormalities. Logistic regression models were fitted to assess the probability of CMR diagnosis at increasing levels of hs-TnT and NT-pro-BNP.
Results Of patients with a normal echocardiographic examination, 23/33 (70%) received a diagnosis using CMR. Pathological echocardiography identified patients with a diagnosis using CMR with a sensitivity of 77%, specificity 38%, positive predictive value 82%, and negative predictive value 30%, respectively. There was no level of hs-TnT or NT-pro-BNP below which a CMR diagnosis could be reliably excluded.
Conclusions The majority of patients with MINOCA and a normal echocardiogram will receive a diagnosis by CMR. A CMR diagnosis was common even among patients with low levels of biomarkers. CMR should be recommended regardless of echocardiographic findings and hs-TnT or NT-pro-BNP levels in patients with MINOCA.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the Swedish Research Council (grant no. 2013-02190), Stockholm county council (grant no. 20150051, 20170053), and the Swedish Heart and Lung Foundation (grant no. 20150612, 20150423, 20170669).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Stockholm Regional Board of Ethics (2014/131-31/1, 2014/1546-32) gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
Abbreviations
- CMR
- cardiac magnetic resonance imaging
- GLS
- global longitudinal strain
- hs-TnT
- high sensitive troponin T
- MI
- myocardial infarction
- MINOCA
- myocardial infarction with non-obstructed coronary arteries
- NPV
- negative predictive value
- OCT
- optimal coherence tomography
- PPV
- positive predictive value
- RWMA
- regional wall motion abnormalities
- TTS
- takotsubo syndrome.
